β2-adrenergic receptor polymorphism and venous thromboembolism

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

Thromb Haemost 2008; 99(01): 99-240
DOI: 10.1160/TH07-08-0520

Letters to the Editor

Schattauer GmbH

Authors

Aaron R Folsom

¹Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, USA
James M Peacock

¹Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, USA
Eric Boerwinkle

²University of Texas Health Science Center, Human Genetics Center and Institute of Molecular Medicine, Houston, Texas, USA
Mary Cushman

³Departments of Medicine and Pathology, University of Vermont, Colchester, Vermont, USA

Received: 24. August 2007

Accepted after major revision: 03. Oktober 2007

Publikationsdatum:
24. November 2017 (online)

References
1 Zee RYL, Cook NR, Cheng S. et al. Polymorphism in the β₂-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: A multilocus, population-based, prospective genetic analysis. Circulation 2006; 113: 2193-2200.

Reference Link Ris
Crossref PubMed Suche in Google Scholar
2 Nossent AY, Dai L, Rosendaal FR. et al. Beta 2 adrenergic receptor polymorphisms: association with factor VIII and von Willebrand factor levels and the risk of venous thrombosis. J Thromb Haemost 2005; 3: 405-407.

Reference Link Ris
Crossref PubMed Suche in Google Scholar
3 O’Donnell J, Manning RA, Laffan MA. Beta-adrenergic receptor polymorphisms in patients with elevated factor VIII levels with venous thrombosis. Br J Haematol 2003; 123: 139-141.

Reference Link Ris
Crossref PubMed Suche in Google Scholar
4 The ARIC Investigators.. The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. Am J Epidemiol 1989; 129: 687-702.

Reference Link Ris
Crossref PubMed Suche in Google Scholar